Chlamydia pneumoniae is a common cause of acute respiratory infections in humans. We evaluated mice as experimental animals for C. pneumoniae. Intranasal inoculation of Swiss Webster mice with C. pneumoniae induced a prolonged course of lung infection, as demonstrated by reisolation of organisms from lungs (at 42 days) and persistence of lung pathology (>60 days). The lung pathology was characterized by patchy interstitial pneumonitis with predominately polymorphonuclear leukocyte infiltration in the eariy and mononuclear cell infiltration in the later stages of infection. Inoculated mice developed serum immunoglobulin G antibody responses and partial resistance against rechallenge inoculation. The other mouse strains tested, Icr, BALB/cAnN, C57BL/6N, C3IIVHeN, and B6C3F1, were shown to be susceptible to C. pneumoniae. The mouse model should be useful for investigating the immunopathogenesis of C. pneumoniae infections.
Chlamydia pneumoniae strain TWAR has been recognized as the third species of Chlamydia (7) . So far, only one serovar or strain (TWAR) has been found. The TWAR organism has been previously established as an important cause of respiratory infections, being associated with 5 to 10% of cases of pneumonia, bronchitis, and sinusitis (5, 6) . Infection with TWAR is very common. Population antibody prevalence studies have shown that more than 50% of adults worldwide have antibody (5, 6) . While antibody is infrequent in children under the age of 5, incidence studies have shown antibody conversion of 6 to 9%/year in children from the ages of 5 to 14, with lower rates in older persons (1) . The prevalence of antibody continues to increase throughout adulthood, and it is highest in the elderly. TWAR infections, which may be more asymptomatic in the young, often result in pneumonia in the elderly. The organism is susceptible to macrolides and tetracyclines. Treatment of symptomatic illness is often successful, but eradication of the organism is difficult. Recently, C. pneumoniae has been associated with atherosclerosis and coronary artery disease (14, 17) .
No information is available on the pathology of C. pneumoniae infections, and no successful animal model has been reported.
Mice are a natural host for two pneumonia-causing chlamydial agents, the meningopneumonitis strain of Chlamydia psittaci (2, 4, 9) and the mouse pneumonitis strain of Chlamydia trachomatis (15) . Intranasal inoculation of mice with the human biovars of C. trachomatis, i.e., trachoma and lymphogranuloma venereum, has been previously shown to induce pneumonitis (3, 8, 12) . In classifying TWAR as belonging to a separate species, C pneumoniae, we showed that mice were susceptible to intranasal inoculation with C. pneumoniae (11).
Here we report on a mouse model of pneumonitis that should be useful for studying the pathogenesis of C. pneumoniae pneumonia.
MATERIALS AND METHODS
C. pneumoniae strain and inoculum preparation. TWAR strain AR-39, a pharyngeal isolate, was used in this study (7) . * Corresponding author.
AR-39 was originally isolated and propagated in HeLa 229 cell culture (11) . Infected cells were harvested with sterile glass beads and ultrasonically disrupted. The cell culturegrown organisms were partially purified by 1 cycle each of low-and high-speed centrifugation, resuspended in sucrosephosphate-glutamic acid (SPG) buffer, and frozen in 0.5-ml aliquots at -70°C. The inoculum preparations contained 5.3
x 10' to 6.6 x 108 inclusion-forming units (IFU) of organisms per ml.
Experimental animals. Several strains of 4-to 5-week-old male mice were used, including outbred mice (Swiss Webster and Icr), inbred mice (BALB/cAnN, C57BL/6N, and C3H/HeN), and hybrid mice (B6C3F1) (Simonsen Laboratory Company, Gilroy, Calif. Histopathology. Lung tissues from infected and control mice were removed from days 2 to 60 and immediately fixed in 10% buffered formalin. Specimens were embedded in paraffin, sectioned, and stained with hematoxylin and eosin.
Determination of intranasal ID50. Serial 10-fold dilutions of inoculum were prepared in SPG buffer. Each dilution was inoculated intranasally into four mice. Mice were killed on day 4 postinoculation to obtain lungs for the infectivity assay. The 50% intranasal infective dose (intranasal ID50) was calculated by the method of Reed and Muench (16) .
RESULTS
Susceptibilities of different strains of mice to C. pneumoniae. To select the most suitable strain of mouse for our experiments, we compared the susceptibilities of the six strains of mice. On the basis of preliminary studies, each mouse was inoculated with 2.7 x 107 IFU of organisms and the infectivity assay was done on day 11. As shown in Table 1 , all six strains of mice were susceptible to C. pneumoniae. No significant differences were found among the six strains of mice in mean titers of organism recovery from lungs (P > 0.05 by t test). Deaths were observed with Balb/cAnN, C57BL/6N, and B6C3F1 mice and occurred on days 2 to 7. The highest mortality (four of eight mice) was noted with C57BL/6N mice. Swiss Webster mice showed no deaths, homogeneous susceptibilities, and less individual variation and yielded a high infectivity titer.
Primary infection. Swiss Webster mice were used to study the course of primary infection. At days 2, 4, 7, 11, 15, 21, 28, 35, 42, 49, and 60 after inoculation, six to seven mice were euthanized for reisolation of the organism (four to five mice) and for histopathology (two mice). Blood was saved to obtain serum for serology. Control mice inoculated with SPG buffer were euthanized in parallel at each time point for isolation and histopathological and serological examination.
(i) Clinical observation. The inoculated mice showed weakness and decreased activity for the first 2 days. They consumed less food and water than controls. Ruffled fur was (iv) Histopathology. Gross observation showed a patchy distribution of areas of consolidation in both lungs in the first 2 weeks. The gross appearance of the lungs gradually returned to normal after 2 weeks. The histopathology of lung infections with TWAR was characterized by irregularly distributed interstitial pneumonitis that was most severe on days 2 and 4. These lesions showed extensive infiltration of polymorphonuclear leukocytes, with exudate in alveolar spaces and bronchial lumens (Fig. la) . Areas of lung consolidation were noted. Infiltration was still severe on days 7 and 11, with mixed mononuclear and polymorphonuclear leukocytes (Fig. lb) . After day 15, the infiltrates were mainly mononuclear cells. Mild infiltration persisted through day 49. Minimum infiltrates with foci of mononuclear cells were still noted on day 60. One striking pathological feature was the observation of perivascular and peribronchial lymphoid cell accumulations which began on day 11 and persisted through day 60, the last day of observation (Fig. lc) . No pathological changes were observed for control mice examined at each time interval (Fig. ld) .
Secondary infection. Rechallenge inoculations were conducted to see whether mice recovered from primary infections had developed resistance against infection with TWAR. In order to determine the optimal dosage for rechal- lenge, the intranasal ID50 was determined with Swiss Webster mice. It was equivalent to 7.0 x 103 IFU. Rechallenge inoculations with 20 ID50 per mouse were given on day 70 or 100 after the primary inoculation. Attempted isolations from lungs at days 70 and 100 were negative with four mice examined for each time.
The results showed that mice recovered from primary infections were partially resistant to reinfections (Table 3) . More than half (8 of 13) of previously infected mice resisted reinfection, while only one control mouse was not infected by the 20 ID50 inoculum when challenged on day 70 after primary infection (P < 0.02 by Fisher exact two-tailed test). (10) . Because human pathology of C. pneumoniae infections has not been described, it is not known whether the same lung pathological changes occur in human C. pneumoniae infections.
The inbred and hybrid mice tested were susceptible to C. pneumoniae infections, but we did not follow the course of disease. Use of inbred and hybrid mice may provide an additional tool for studying the immune mechanisms of C. pneumoniae infections.
We have described a mouse model of C. pneumoniae pneumonitis. This model offers a nonfatal, prolonged course of pneumonitis with similarities to the human disease, which should be useful for studying pathology, immunity, and treatment of C. pneumoniae infections. Mice that had recovered from C. pneumoniae infections developed partial resistance to reinfection. This finding suggests that the mouse model will be useful for studies of prevention of infection.
